Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Franco-Nevada: Second-Quarter Results Analysis

4h seekingalpha
Despite second-quarter results that were shy of estimates primarily in revenues, it should be wrong to classify this quarter as a miss.
WPM SAND SSL SDDXF OKSWF CTLR GDX SNXZF RGLD OR OSKGF CLR FNV RGL

4
Gold Miners' Q2'18 Fundamentals

2018-08-18 seekingalpha - 1
The major gold miners’ fundamentals are quite strong based on their recently-reported Q2’18 results. While production declined sharply, these miners still held the line on all-in sustaining costs.
AULGF ABX GFI.WI KGC NEM GDX K AU GFI AGG GFIOF ABX

4
Gold Miners Look Cheap If You Ignore History

2018-08-17 seekingalpha
VanEck Vectors Gold Miners ETF (GDX) took a monstrous hit on August 15 falling by 6% to a new 52-week low. Since its inception, GDX has radically diverged from the Gold price itself.
ABX NEM GDX GG FNV ABX

1
Gold Is Melting: Why This Is No Time To Panic

2018-08-17 seekingalpha
Gold has been dented in recent months, crashing by nearly 15% from peak to trough in just 4 months.
O87 GDX NASH GLD SLV

2
While The S&P 500 Is Close To An All-Time High, There Are So Many Assets At Record Lows

2018-08-14 seekingalpha
On the other hand, there are plenty of markets and assets that trade at multi-year lows and have suffered tremendous losses. Turkey, anyone?
GLRE AAPL GDX MSFT KBA KWEB SLV

5
Weight Of Debt Supports Wait On Gold

2018-08-10 seekingalpha - 1
Gold and Gold Stocks Decline in July on U.S. Dollar Strength, Disappointing Q2 Results of Majors
ABX GDX AEM GG ABX GDXJ

0
Resolute Mining has shares purchased by renowned gold ETFs

2018-08-09 proactiveinvestors.com.au
Resolute Mining Ltd (ASX:RSG) has had substantial shareholder, Van Eck Associates Corporation, increase its stake in the company to 12.04% from 11.01%.
RSG RMGGY RMGGF GDX GDXJ

1
Gold Stocks' Autumn Rally 3

2018-08-04 seekingalpha
Gold-stock seasonals argue this sector is right on the verge of a major autumn rally. Augusts and Septembers are the best couple-month span of the year for gold stocks seasonally.
GDX GLD

0
Trade of the Day: VanEck Vectors Gold Miners ETF (GDX)

2018-08-03 investorplace
To receive further updates on this VanEck Vectors Gold Miners ETF (NYSEARCA:GDX) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Power Options Weekly today.
GDX

0
Gold Weekly: Stand Ready To Embrace The Forthcoming Bullish Wave

2018-08-03 seekingalpha
Sentiment toward gold is excessively bearish - specs have never been that short on the Comex.
GDX

2
Gold Shorts Near Record!

2018-07-28 seekingalpha - 1
Speculators’ gold-futures shorting just surged at extreme near-record rates to extreme near-record levels! That’s what drove this summer’s worse-than-usual weakness.
GDX GLD

0
Gold Weekly: Feels Like The Endless Summer?

2018-07-25 seekingalpha
At current price levels, going long gold offers an interesting reward-to-risk ratio, given the excessive bearishness.
GDX

0
Do Gold Stock Investors Know A Secret?

2018-07-20 seekingalpha
It has been a long two months for gold, as the yellow metal price has plunged to its lowest level since 2017. Despite this performance, however, gold mining stocks have had a far better performance both in actual and relative terms. In this report, we’ll focus on the relative strength which the leading mining stocks are still showing even as gold continues its bear market. This begs the question, “Do gold stock investors know something (bullish) about gold’s future that we don’t?”
GDX IAU

1
Gold and Precious Metals Moving Toward Lows of the Year

2018-07-17 247wallst
Gold has had a rough 2018. Despite some of the international trade worries and international suspense, the reality is that most investors are just not looking for the “ultimate safety trade” that is often the reason for gold’s rally. Much of this weakness in gold has spilled over into other precious metals as the U.S. dollar strength and the promise of higher interest rates ahead are keeping gold buyers on the sidelines.
O87 GDX PPLT GLTR GLD SLV

0
Gold-Stock Summer Lows

2018-07-14 seekingalpha
Gold stocks bottom around the middles of market summers. These major summer-doldrums lows offer the best seasonal buying opportunities of the entire year.
PVG PVG GDX GDXJ

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 92189F106